This Notice was RESCINDED, NHLBI participation in the Notice of Special Interest (NOSI) will continue.

RESCINDED


RESCINDED - Notice of NHLBI Participation in NOT-OD-20-121 "Notice of Special Interest (NOSI): Limited Competition for Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations"
Notice Number:
NOT-HL-20-805

Key Dates

Release Date:

July 24, 2020

Related Announcements

NOT-OD-20-131 - Notice of Pre-Application Webinar for the RADx-UP Initiative
PA-20-135 - Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)
NOT-OD-20-120 - Notice of Special Interest (NOSI): Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations
NOT-OD-20-119- Notice of Special Interest (NOSI): Emergency Competitive Revisions for Social, Ethical, and Behavioral Implications (SEBI) Research on COVID-19 Testing among Underserved and/or Vulnerable Populations
RFA-OD-20-013 - Emergency Awards: RADx-UP Coordination and Data Collection Center (CDCC) (U24 Clinical Trial Optional)
NOT-OD-20-138 - Notice of Correction to NOT-OD-20-119, NOT-OD-20-120, NOT-OD-20-121 Eligibility Section

NOT-OD-20-121 - Notice of Special Interest (NOSI): Limited Competition for Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations

Issued by

National Heart, Lung, and Blood Institute (NHLBI)

Purpose

The purpose of this Notice is to inform potential applicants that NHLBI's participation in NOT-OD-20-121 "Notice of Special Interest (NOSI): Limited Competition for Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations" will cease on July 31, 2020. An application submitted in response to NOT-OD-20-121 that is intended for NHLBI and received on or later than August 01, 2020 will be withdrawn.

Inquiries

Please direct all inquiries to:

Kate Stoney, PhD
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-6670
Email: stoneyc@nhlbi.nih.gov


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices